Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
02/2013
02/13/2013CN102933575A Yclohexyl-azetidinyl antagonists of ccr2
02/13/2013CN102933572A Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
02/13/2013CN102933561A Pharmaceutically active disubstituted triazine derivatives
02/13/2013CN102933554A Crosslinking reagents, methods, and compositions for studying protein-protein interactions
02/13/2013CN102924437A 3-piperazine-4-indol maleimide compound and preparation and application thereof
02/13/2013CN102924377A Synthetic method of 3,4,5-substituted pyrazole compound
02/13/2013CN102924364A Heterocyclic compound and organic light-emitting diode comprising the same
02/13/2013CN101245043B Aza-heterocyclic compounds used to treat neurological disorders and hair loss
02/12/2013US8372987 Title compound is Veliparib, a Poly(ADP-ribose) polymerase i.e. PARP inhibitor; anticancer agent
02/12/2013US8372985 Process of making α-aminooxyketone/α-aminooxyaldehyde and α-hydroxyketone/α-hydroxyaldehyde compounds and a process of making reaction products from cyclic α, β-unsaturated ketone substrates and nitroso substrates
02/12/2013US8372973 Prokineticin 1 receptor antagonists
02/12/2013US8372971 Heterocyclic compounds and methods of use
02/12/2013US8372858 Compounds and compositions as protein kinase inhibitors
02/12/2013US8372850 Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases
02/12/2013US8372836 Spray dried formulation
02/12/2013CA2708502C Perhydroquinoxaline derivatives
02/12/2013CA2596527C Igf-1r inhibitors
02/07/2013WO2013020062A1 Quinazoline compounds as serine/threonine kinase inhibitors
02/07/2013WO2013019561A1 Nuclear transport modulators and uses thereof
02/07/2013WO2013019548A1 Hydrazide containing nuclear transport modulators and uses thereof
02/07/2013WO2013019079A2 Composition containing 5-hydroxyindole compounds or sponge scalarispongia sp. extracts as active ingredients for prevention and treatment of cancer diseases
02/07/2013WO2013018804A1 Uracil derivative and use thereof for medical purposes
02/07/2013WO2013017657A1 Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament
02/07/2013WO2013017073A1 Quinazoline derivative, composition having the derivative, and use of the derivative in preparing medicament
02/07/2013WO2012073041A3 Inhibitors of apurinic/apyrimidinic endonuclease 1 (ape1) and their use
02/07/2013WO2011045807A3 A novel process to manufacture (2r,3s)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1h-1,2,4-triazol-1-yl)butan-2-ol
02/07/2013WO2010146595A3 Novel polymorphs of flibanserin hydrochloride
02/07/2013US20130035484 Intermediates useful for the synthesis of pyrrolobenzodiazepines
02/07/2013US20130035346 Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors
02/07/2013US20130035342 Compound Suitable for the Treatment of Synucleopathies
02/07/2013US20130035329 Therapeutically active compositions and their methods of use
02/07/2013US20130035328 Antiviral compounds and methods
02/07/2013US20130035325 Kinase inhibitors
02/07/2013US20130034520 Hepatitis C Virus Inhibitors
02/07/2013US20130034501 Diarylhydantoin compounds
02/07/2013US20130032788 Carbazole-based compound and organic light-emitting diode comprising the same
02/07/2013US20130032787 Heterocyclic compound and organic light-emitting device including the same
02/07/2013US20130032786 Organic compound and organic electroluminescent device employing the same
02/07/2013US20130032764 Materials for organic electroluminescence devices
02/07/2013CA2844058A1 Quinazoline compounds as serine/threonine kinase inhibitors
02/07/2013CA2843836A1 Uracil derivative and use thereof for medical purposes
02/07/2013CA2843805A1 Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament
02/07/2013CA2842364A1 Nuclear transport modulators and uses thereof
02/07/2013CA2842362A1 Hydrazide containing nuclear transport modulators and uses thereof
02/06/2013EP2554545A1 Carbazole-based compound and organic light-emitting diode comprising the same
02/06/2013EP2554538A1 Succinimide compound, lubricating oil additive, and lubricating oil composition
02/06/2013EP2552909A1 4 - aminopyrimidine derivatives and their as as adenosine a2a receptor antagonists
02/06/2013EP2552908A2 Heterocyclic compounds and their uses
02/06/2013EP2552888A1 "trpv1 vanilloid receptor antagonists with a bicyclic portion"
02/06/2013EP2552214A1 Pyrazolyl-pyrimidines as kinase inhibitors
02/06/2013EP2552211A1 Indazolyl-pyrimidines as kinase inhibitors
02/06/2013EP2552209A1 Novel spiro imidazolone derivatives as glucagon receptor antagonists, compositions, and methods for their use
02/06/2013EP2552208A1 Imidazolyl-imidazoles as kinase inhibitors
02/06/2013CN1950082B Bicyclic and bridged nitrogen heterocycles
02/06/2013CN1938298B Methods for minimizing thioamide impurities
02/06/2013CN102918036A 5-amino-3,6-dihydro-1h-pyrazin-2-one derivatives useful as inhibitors of beta-secretase (bace)
02/06/2013CN102918035A 2 -amino- pyrimidine derivatives useful as inhibitors of jnk
02/06/2013CN102918031A Radiolabeled compounds and methods thereof
02/06/2013CN102911163A Quinazoline derivatives, composition containing derivatives and pharmaceutical application of derivatives
02/06/2013CN102911162A Organic compound and organic electroluminescent device employing the same
02/06/2013CN102911161A 病毒聚合酶抑制剂 Viral polymerase inhibitors
02/06/2013CN102911159A Carbazole-based compound and organic light-emitting diode comprising the same
02/06/2013CN102911124A Hydroxy-pyrimidone compound and preparation method and application thereof
02/06/2013CN102911112A Heterocyclic compound and organic light-emitting device including the same
02/06/2013CN102911110A N, N-disubstituted-N'-phthaloyl group-1, 3-diamine derivative and preparation method thereof
02/06/2013CN102911103A 1-(3, N, N-disubstituted amino group propyl group)-pyrrolidone derivative and preparation method thereof
02/06/2013CN101809018B Solids forms of ( s) -ethyl 2-amin0-3- (4- (2 -amino- 6- ( (r) -1- (4-chl0r0-2- o-methyl-ih-pyrazol- 1-yl) phenyl) -2, 2, 2-trifluorethoxy) -pyrimidin-4-yl) phenyl) propanoate and using method thereof
02/06/2013CN101778834B Novel herbicides
02/06/2013CN101426784B Novel method for producing pyrimidine compound
02/05/2013US8367845 Ionic viscoelastics and viscoelastic salts
02/05/2013US8367844 Microbiocidal heterocycles
02/05/2013US8367839 Tetrakis(1-imidazolyl) borate (BIM4) based zwitterionic and related molecules used as electron injection layers
02/05/2013US8367825 Substituted pyrimidinyl oxime kinase inhibitors
02/05/2013US8367713 Inhibition and dispersion of bacterial biofilms with imidazole-triazole derivatives
02/05/2013US8367710 Bicyclo-substituted pyrazolon azo derivatives, preparation process and pharmaceutical use thereof
02/05/2013US8367673 Substituted diketopiperazines as oxytocin antagonists
02/05/2013US8367664 Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors
02/05/2013US8367654 8-AZA tetracycline compounds
02/05/2013US8367653 Azetidinyl diamides as monoacylglycerol lipase inhibitors
02/05/2013US8367358 Reagent, kit and method for differentiating and counting leukocytes
02/05/2013US8367065 Targeted polymeric prodrugs containing multifunctional linkers
02/05/2013CA2672190C 4-(heterocyclyl)alkyl-n-(arylsulfonyl) indole compounds and their use as 5-ht6 ligands
02/05/2013CA2591033C Heterocyclic aspartyl protease inhibitors
02/05/2013CA2589127C 3-(indolyl)-4-arylmaleimide derivatives and their use as angiogenesis inhibitors
02/05/2013CA2526872C Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
02/05/2013CA2520894C Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses
01/2013
01/31/2013WO2013016441A1 Hiv integrase inhibitory oxoisoindoline sulfonamides
01/31/2013WO2013016178A1 N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors
01/31/2013WO2013014165A1 Substituted picolinic acids and pyrimidine-4-carboxylic acids, method for the production thereof, and use thereof as herbicides and plant growth regulators
01/31/2013WO2013014162A1 Heterocyclyl pyrimidine analogues as jak inhibitors
01/31/2013WO2013014104A1 Bis-indolic derivatives, their uses in particular as antibacterials
01/31/2013WO2013014039A1 Alkynyl substituted pyrimidinyl-pyrroles active as kinases inhibitors
01/31/2013WO2013014038A1 3-oxo-2,3-dihydro-1h-indazole-4-carboxamide derivatives as parp-1 inhibitors
01/31/2013WO2013013614A1 4-(3-heteroarylarylamino)quinazoline and 1-(3-heteroarylarylamino)isoquinoline as hedgehog pathway inhibitor and use thereof
01/31/2013US20130030180 Methods of Facilitating Neural Cell Survival Using GDNF Family Ligand (GFL) Mimetics or RET Signaling Pathway Activators
01/31/2013US20130030171 Pyrimidinyl Aryl Urea Derivatives being FGF Inhibitors
01/31/2013US20130030166 Minor groove binder phosphoramidites and methods of use
01/31/2013US20130030019 Novel prolylcarboxypeptidase inhibitors
01/31/2013US20130030004 Gyrase inhibitors and uses thereof
01/31/2013US20130030003 9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazoline-6-yloxy]-1,4-diaza-spiro[5.5]undecane-5-one dimaleate, use thereof as a medicament and method for the production thereof
1 ... 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 ... 626